ArticleJournal for immunotherapy of cancer2026
Plasma proteomics predicts pathological complete response and reveals LIF as a potential mediator of resistance to neoadjuvant immunochemotherapy in resectable NSCLC.
Shoucheng Feng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.